How Clinical Diagnostics Will Drive Precision Medicine
For Strata Oncology, clinical diagnostics is critical for the move to a precision medicine model. It’s doing so with its Strata Select test.
Read More
Search Results for: lung cancer
FDA Approves Fountain Medicine’s CDx for Eli Lilly’s Retevmo to Treat Solid Tumor Patients
The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.
Read More
DELFI Diagnostics Unveils Blood Test for Enhanced Lung Cancer Screening
DELFI’s blood test provides results by determining the likelihood of detecting lung cancer through low-dose CT, with an NPV of 99.7 percent.
Read More
Blood Tests Identify NSCLC Patients Who May Benefit from Immunotherapies
Liquid biopsies may identify NSCLC patients undergoing immunotherapy who could benefit from treatment with additional drugs.
Read More
Hackensack Meridian Health Research Institute Establishes Cancer Diagnostics Company
EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.
Read More